La/SSB Activators
The class of La/SSB activators encompasses a diverse array of chemicals that intricately modulate the activities of the La/SSB protein, a multifunctional RNA-binding protein involved in various aspects of RNA metabolism. These activators exert their effects through both direct and indirect mechanisms, highlighting the interconnected nature of cellular processes influenced by these compounds. Direct activators, such as Actinomycin D, Actinomycin C, and Actinomycin X2, function by inhibiting transcription, leading to an increased demand for La/SSB during RNA synthesis and processing. Indirect activators, including Doxorubicin, Rifampicin, and Etoposide, impact La/SSB activity through their influence on DNA damage response pathways. These chemicals induce DNA lesions, altering the availability of RNA substrates and subsequently affecting the binding and function of La/SSB. The class also includes compounds like Flavopiridol and 5-Fluorouracil (5-FU), which modulate cell cycle progression and nucleotide metabolism, respectively, indirectly influencing the activities of La/SSB within the broader context of cellular processes.
Understanding the specific biochemical and cellular pathways influenced by these diverse chemicals enhances our comprehension of the intricate regulatory networks governing La/SSB activation in the context of RNA metabolism. The interconnectedness of transcription, DNA damage response, and cell cycle regulation underscores the complexity of La/SSB modulation by these activators, providing valuable insights into the intricate control of RNA-related processes within the cellular milieu.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D indirectly activates La/SSB by inhibiting transcription. As an RNA synthesis inhibitor, it impacts the availability of RNA substrates, leading to increased binding of La/SSB to RNA and enhancing its activity. This indirect activation showcases the regulatory role of Actinomycin D in modulating the cellular processes associated with La/SSB. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin indirectly activates La/SSB by influencing RNA synthesis. Through its role as an anthracycline antibiotic, Doxorubicin interferes with RNA production, affecting the RNA substrates available for La/SSB binding. This indirect activation highlights the interconnected nature of cellular processes influenced by Doxorubicin and their impact on the activity of La/SSB. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin indirectly activates La/SSB by inhibiting bacterial RNA polymerase. While primarily used as an antibiotic against bacterial infections, Rifampicin can influence host cell RNA synthesis, indirectly affecting La/SSB activity. This indirect activation underscores the multifaceted impact of Rifampicin on cellular processes, extending to the modulation of La/SSB-related pathways. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin indirectly activates La/SSB by inhibiting DNA topoisomerase I. As a topoisomerase inhibitor, Camptothecin induces DNA damage and alters the availability of RNA substrates, indirectly impacting the binding and activity of La/SSB. This indirect activation highlights the cross-talk between DNA and RNA-related processes influenced by Camptothecin and its repercussions on La/SSB function. | ||||||
Ellipticine | 519-23-3 | sc-200878 sc-200878A | 10 mg 50 mg | $145.00 $569.00 | 4 | |
Ellipticine indirectly activates La/SSB by modulating DNA topoisomerases and inducing DNA damage. Through its interaction with DNA, Ellipticine affects RNA substrate availability, indirectly influencing the binding and activity of La/SSB. This indirect activation demonstrates the interconnected nature of DNA damage response pathways and their impact on RNA-binding proteins like La/SSB. | ||||||
Flavopiridol | 146426-40-6 | sc-202157 sc-202157A | 5 mg 25 mg | $78.00 $259.00 | 41 | |
Flavopiridol indirectly activates La/SSB by inhibiting cyclin-dependent kinases (CDKs). As a CDK inhibitor, Flavopiridol affects cell cycle progression and RNA synthesis, indirectly impacting La/SSB activity. This indirect activation highlights the interplay between cell cycle regulation, transcription, and the function of La/SSB within the broader context of cellular processes influenced by Flavopiridol. | ||||||
Actinomycin V | 18865-48-0 | sc-507379 | 1 mg | $450.00 | ||
Actinomycin V indirectly activates La/SSB by inhibiting transcription, akin to Actinomycin D and Actinomycin C. Its interference with RNA synthesis leads to increased binding of La/SSB to RNA, enhancing its activity. This indirect activation underscores the conserved regulatory impact of Actinomycin X2 on the transcription processes that influence the function of La/SSB in cellular RNA metabolism. | ||||||
Mitoxantrone | 65271-80-9 | sc-207888 | 100 mg | $285.00 | 8 | |
Mitoxantrone indirectly activates La/SSB by influencing DNA topoisomerases and inducing DNA damage. Through its impact on DNA structure, Mitoxantrone alters RNA substrate availability, indirectly affecting the binding and activity of La/SSB. This indirect activation emphasizes the interconnected regulatory networks between DNA damage response pathways and the function of La/SSB in RNA-related processes influenced by Mitoxantrone. | ||||||
Mitomycin C | 50-07-7 | sc-3514A sc-3514 sc-3514B | 2 mg 5 mg 10 mg | $66.00 $101.00 $143.00 | 85 | |
Mitomycin C indirectly activates La/SSB by inducing DNA crosslinks and damaging DNA. Its impact on DNA structure alters RNA substrate availability, indirectly influencing the binding and activity of La/SSB. This indirect activation underscores the intricate relationship between DNA damage response mechanisms induced by Mitomycin C and their downstream effects on the function of La/SSB in cellular RNA metabolism. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
Etoposide indirectly activates La/SSB by inducing DNA damage and inhibiting topoisomerase II. Through its role in DNA damage response pathways, Etoposide alters RNA substrate availability, indirectly impacting the binding and activity of La/SSB. This indirect activation emphasizes the cross-talk between DNA damage response mechanisms and the function of La/SSB in cellular RNA metabolism influenced by Etoposide. | ||||||